ESHAML 2017 Cathy Smith

Clinical resistance mechanisms that have been observed in FLT3 inhibitor kinase therapy.

Interview with Cathy Smith MD, UCSF Medical Center in San Francisco 

ESH AML, Estoril Portugal, 5 – 7 October 2017 

4th International Conference on Acute Myeloid Leukemia “Molecular and Translational”: Advances in Biology and Treatment.

 

0818HEM1005765
×

Ask Speakers

×

Medical Information Request